Insulin-like growth factor binding proteins related to progression-free survival (PFS) and overall survival (OS) in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy

被引：2
|
作者：
Karmali, R. [1 ]
Fidler, M. J. [1 ]
Cela, I. [1 ]
Olmsted, G. [1 ]
Rouhi, O. [1 ]
Basu, S. [1 ]
Walters, K. K. [1 ]
Coon, J. [1 ]
Bonomi, P. [1 ]
Borgia, J. A. [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.7553
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7553
引用
收藏
页数：1
相关论文
共 50 条
  • [21] BASELINE POPULATION CHARACTERISTICS AND THE ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ADVANCED NON SMALL CELL LUNG CANCER PATIENTS
    Kulakova, M.
    Hashim, M.
    Pfeiffer, B.
    Postma, M.
    Heeg, B.
    VALUE IN HEALTH, 2017, 20 (09) : A420 - A421
  • [22] SIMULATION AND COMPARISON OF PROGRESSION-FREE SURVIVAL (PFS) AMONG PATIENTS WITH NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) RECEIVING SEQUENTIAL THERAPY
    Chouaid, C.
    Walzer, S.
    Lister, J.
    Gultyaev, D.
    Vergnenegre, A.
    de Marinis, F.
    Meng, J.
    de Castro, J.
    Crott, R.
    Kleman, M.
    Ngoh, C. A.
    VALUE IN HEALTH, 2014, 17 (03) : A70 - A70
  • [23] Al Serial Image Prediction of Progression-Free Survival (PFS) for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients Treated with Chemoradiation (CRT) and Durvalumab Consolidation
    Veeraraghavan, H.
    Jiang, J.
    Jee, J.
    Lebow, E. S.
    Deasy, J. O.
    Rimner, A.
    Shaverdian, N.
    Yu, H.
    Gomez, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E68 - E68
  • [24] Overall survival (OS) of selected patients (Pts) with non-small cell lung cancer (NSCLC) receiving nivolumab beyond progression
    Genova, C.
    Rijavec, E.
    Rossi, G.
    Biello, F.
    Barletta, G.
    Tagliamento, M.
    Grossi, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] Predictive Factors for Poor Progression-free Survival in Patients with Non-small Cell Lung Cancer Treated with Nivolumab
    Taniguchi, Yoshihiko
    Tamiya, Akihiro
    Isa, Syun-Ichi
    Nakahama, Kenji
    Okishio, Kyoichi
    Shiroyama, Takayuki
    Suzuki, Hidekazu
    Inoue, Takako
    Tamiya, Motohiro
    Hirashima, Tomonori
    Imamura, Fumio
    Atagi, Shinji
    ANTICANCER RESEARCH, 2017, 37 (10) : 5857 - 5862
  • [26] Use of progression-free survival (PES) as an endpoint in advanced non-small cell lung cancer (NSCLC) trials: FDA perspective
    Malik, S. M.
    Ibrahim, A.
    Sridhara, R.
    Justice, R. L.
    Pazdur, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Use of progression-free survival (PFS) to predict overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
    Halabi, S.
    Rini, B. I.
    Stadler, W. M.
    Small, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] RELATIONSHIP OF PROGRESSION-FREE SURVIVAL, POST-PROGRESSION SURVIVAL AND RESPONSE WITH OVERALL SURVIVAL IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER OF INDIVIDUAL-LEVEL
    Imai, Hisao
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Shukuya, Takehito
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    RESPIROLOGY, 2013, 18 : 85 - 85
  • [29] Relationship between progression-free survival and overall survival in patients with advanced non-small cell lung cancer treated with anticancer agents after first-line treatment failure
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Okamoto, Norio
    Yamadori, Tadahiro
    Tamiya, Motohiro
    Morishita, Naoko
    Shiroyama, Takayuki
    Takeoka, Sawa
    Osa, Akio
    Azuma, Yuichiro
    Kawase, Ichiro
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (02) : 121 - 128
  • [30] Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer
    Komaki, Ritsuko
    Allen, Pamela K.
    Wei, Xiong
    Blumenschein, George R.
    Tang, Ximing
    Lee, J. Jack
    Welsh, James W.
    Wistuba, Ignacio I.
    Liu, Diane D.
    Hong, Waun Ki
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 317 - 324
12345